<qa>  What is the STUDY of the OPEN-LABEL EXTENSION STEFFICACY AND SAFETY OF DEFERASIROX IN NON-TRANSFUSION DEPENDENT THALASSEMIA PATIENTS WITH IRON OVERLOAD AND A ONE YEAR OPEN-LABEL EXTENSION STUDY: 